RYTHM, Inc. (RYM)
Consumer Defensive · NCM
Fundamentals
Valuation and ratings
RYTHM, Inc. trades at USD19.50, close to the USD17.02 our discounted cash flow model puts on the business. On this measure the market and the model broadly agree, so the interesting question is which of them is wrong.
Our moat model scores it 32 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About RYTHM, Inc.
RYTHM, Inc. provides solutions for the cannabis and hemp industry in the United States. The company offers consumers hemp-derived tetrahydrocannabinol beverages, as well as other hemp-derived products through retailers, online, and direct-to-retail partnerships. It also provides cocktails in four flavors, such as classic Lime Jalapeño Margarita, Mango Margarita, Paloma, and Ranch Water; and an alternative to alcoholic beverages, such as Total Wine, ABC Fine Wine & Spirits, and Binny's. In addition, the company licenses its brands to be manufactured and distributed. It sells its products under the RYTHM, incredibles, Dogwalkers, Beboe, &Shine, Doctor Solomon's, Good Green, and Señorita brands. The company was formerly known as Agrify Corporation and changed its name to RYTHM, Inc. in August 2025. RYTHM, Inc. was incorporated in 2016 and is headquartered in Rolling Meadows, Illinois.
RYM passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Common questions
Is RYTHM, Inc. (RYM) undervalued?
Against our discounted cash flow estimate of USD17.02, RYM at USD19.50 is 13% above fair value. That is one model's answer, not a recommendation, and most of a DCF's output sits in a terminal value nobody can forecast.
The full research page for RYM, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.